Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Expert Review of Cardiovascular Therapy|October 9, 2018
Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic reviewElin Danielsen Lunde, Peter Brønnum Nielsen, Sam Riahi, et al.
BMJ Open|June 1, 2021
Socioeconomic inequality in oral anticoagulation therapy initiation in patients with atrial fibrillation with high risk of stroke: a register-based observational studyElin Danielsen Lunde, Albert Marni Joensen, Kirsten Fonager, et al.
American Heart Journal|January 27, 2025
Randomized comparison of the combined Sirolimus eluting and endothelial progenitor cell combo Stent vs. biolimus eluting absorbable polymer coated biomatrix alpha stent in patients undergoing percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for randomized trials with clinical outcome (SORT OUT) XI trialAshkan Eftekhari, Evald Høj Christiansen, Jens Flensted Lassen, et al.
European Journal of Preventive Cardiology|October 25, 2011
Changes in medical treatment six months after risk stratification with HeartScore and coronary artery calcification scanning of healthy middle-aged subjectsMette Hjortdal Sørensen, Oke Gerke, Jess Lambrechtsen, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL studyAnders G Olsson, Christina Lindahl, Ingar Holme, et al.
General Hospital Psychiatry|July 24, 2021
New onset anxiety and depression in patients with an implantable cardioverter defibrillator during 24 months of follow-up (data from the national DEFIB-WOMEN study)Susanne S Pedersen, Jens Cosedis Nielsen, Sonja Wehberg, et al.
The American Journal of Cardiology|May 12, 2009
Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarctionTimo E Strandberg, Ingar Holme, Ole Faergeman, et al.
Atherosclerosis|March 31, 2009
Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL)Ingar Holme, Timo E Strandberg, Ole Faergeman, et al.
Annals of Medicine|January 23, 2009
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL)Ingar Holme, Nilo B Cater, Ole Faergeman, et al.
The American Journal of Cardiology|July 21, 2010
Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trial)Terje R Pedersen, Nilo B Cater, Ole Faergeman, et al.
Pageof 13